HEADLINES:  

The bio-pharmaceutical sector in India accounted for the largest chunk of the biotech industry, with a share of 62 per cent in total revenues in the financial year of 2012. In the same year, bio-services and the bio-agri segments followed the bio-pharmaceutical segment with shares of 18.3 per cent and 14.9 per cent, respectively.

Growth was fastest in the bio-agri segment (23 per cent in FY12), followed by bio-pharma (19.0 per cent) and bio-services (15.5 per cent). Domestic bio-services sector grew an astounding 102 per cent in FY12 to US$ 109.3 million.

The domestic bio-pharma sector, which accounts for more than 61 per cent of the domestic biotech industry, registered a 26.6 per cent growth in FY12, in comparison the growth in domestic bio-informatics sector was 24 per cent.

Biotech export revenue reached US$ 2.1 billion in FY12, nearly half (48 per cent) of total industry revenue. Over the years, export revenue has grown considerably from US$ 0.4 billion in FY05 to US$ 2.1 billion in FY12 (a CAGR of 25.6 per cent).


Investments, along with outsourcing activities and exports, are key drivers for growth in the biotech sector of India.

Foreign direct investment (FDI) up to 100 per cent is permitted through the automatic route for manufacturers of drugs and pharmaceuticals. According to data released by the Department of Industrial Policy and Promotion (DIPP), the drugs and pharmaceuticals sector has attracted FDI worth Rs 45,980.03 crore (US$ 8.47 billion) between April 2000 and December 2012.

  INDIAN Biotech INDUSTRY AT A Glance IN 2011 - 2012

  Biotechnology Industry Research Assistance Council (BIRAC)

  All India Biotech Association (AIBA)

  back to biotechnology INDUSTRY